|
Volumn 11, Issue 4, 2002, Pages 517-523
|
Long-term outcome after valve replacement with the omnicarbon prosthesis
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
LACTATE DEHYDROGENASE;
WARFARIN;
ADULT;
AGED;
ANTICOAGULANT THERAPY;
AORTA VALVE REPLACEMENT;
ARTICLE;
BLEEDING;
BLOOD CELL COUNT;
COHORT ANALYSIS;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
FUNCTIONAL ASSESSMENT;
HEART HEMODYNAMICS;
HEART VALVE PROSTHESIS;
HEART VALVE REPLACEMENT;
HEMOLYTIC ANEMIA;
HUMAN;
LACTATE DEHYDROGENASE BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MITRAL VALVE REPLACEMENT;
PATIENT SATISFACTION;
PERFORMANCE;
PRIORITY JOURNAL;
PROGNOSIS;
PROSPECTIVE STUDY;
QUALITY OF LIFE;
RHEUMATIC HEART DISEASE;
SURVIVAL;
THROMBOEMBOLISM;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ADULT;
AGED;
AORTIC VALVE;
BIOPROSTHESIS;
COHORT STUDIES;
FEMALE;
FOLLOW-UP STUDIES;
HEART VALVE DISEASES;
HEART VALVE PROSTHESIS;
HUMANS;
LINEAR MODELS;
MALE;
MIDDLE AGED;
MITRAL VALVE;
POSTOPERATIVE COMPLICATIONS;
PROBABILITY;
PROSPECTIVE STUDIES;
PROSTHESIS FAILURE;
QUALITY OF LIFE;
REOPERATION;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0036328742
PISSN: 09668519
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (14)
|